An interactive toolbox for standardizing, validating, simulating, reducing, and exploring detailed biophysical models that can be used to reveal how morpho-electric properties map to dendritic and ...

Willow’s trial begins with tension from the first witness. Dante takes the stand after receiving a mysterious text, telling the truth — but saying just enough to make Alexis panic and object to ...

Depending on the position, the summer job can last for 3- 4 months and is carried out between May and September 2026. Please note that these summer job positions are available for B.Sc. or M.Sc.

Corti, a healthcare AI infrastructure company, today announced a major advance in AI transparency, achieving the #1 position on the Hugging Face Mechanistic Interpretability Benchmark (MIB). The ...

Evidence suggests pythons may be evolving to tolerate colder climates farther north. These invasive snakes are primarily established in South Florida, south of Lake Okeechobee. As sections of the ...

Ensysce Biosciences ( (ENSC)) has provided an announcement. On November 14, 2025, Ensysce Biosciences closed a $4 million convertible preferred stock financing, with the potential for an additional ...

Pacira BioSciences (PCRX) edged higher by 0.4% after an investor pushed the company to explore a sale process. "Due to what we believe is management's unrelenting underperformance, out-of-control ...

Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...

Parse Biosciences co-founders are CTO Charles Roco and CEO Alex Rosenberg. (Parse Photo) Seattle’s Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a ...

Neurocrine Biosciences posts standout Q3 beat as INGREZZA and CRENESSITY drive 28% product sales growth. Neurocrine Biosciences pipeline momentum builds with Phase 3 schizophrenia trial and new MDD ...

Novartis NOVN-0.15%decrease; red down pointing triangle is acquiring Avidity Biosciences RNA 0.20%increase; green up pointing triangle in a $12 billion deal that the Swiss drugmaker said would further ...

Swiss drugmaker Novartis on Sunday said it agreed to acquire US biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare ...